Durability of Protection Against Symptomatic COVID-19 Among Participants of the mRNA-1273 SARS-CoV-2 Vaccine Trial
This cohort study assesses the durability of protection against symptomatic COVID-19 among participants of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine trial.
Authors
- Hana M. El Sahly (ORCID: https://orcid.org/0000-0003-0489-0074)
- COVE Study Group
- Kathleen M. Neuzil (ORCID: https://orcid.org/0000-0001-9480-2714)
- Jacqueline M. Miller (ORCID: https://orcid.org/0000-0002-7083-2182)
- Lawrence Corey (ORCID: https://orcid.org/0000-0002-2179-2436)
- Lindsey Robert Baden (ORCID: https://orcid.org/0009-0004-1752-1926)
- Dan-Yu Lin
- Brandon Essink (ORCID: https://orcid.org/0000-0002-7309-228X)
Institutions
- University of North Carolina at Chapel Hill (US)
Publication Details
- Journal
- UNC Libraries
- Published
- 2025-04-29
- DOI
- https://doi.org/10.17615/rz53-x564
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00